Institute for Animal Health, Pirbright Laboratory, Ash Road, Woking, Surrey GU240NF, UK.
Vaccine. 2012 Jan 5;30(2):112-5. doi: 10.1016/j.vaccine.2011.10.100. Epub 2011 Nov 7.
Despite the widespread use of bluetongue serotype 8 (BTV-8) inactivated vaccines across Europe from 2008 to 2011, two very practical questions remain unanswered about the length of persistence of group-specific antibodies in milk and serum post-vaccination and the duration of protection beyond one year post-vaccination. This study has firstly revealed that group-specific antibodies persist at high levels in milk and serum in the majority of cattle for at least 3 years post-vaccination, thus removing the option of using these animals in ELISA-based surveillance programmes. Secondly neutralising antibodies have been shown to persist in the majority of cattle for at least 3 years post-vaccination, indicating that the cattle are likely to be protected for this time period. This extended duration of protection may have contributed towards the rapid and efficient eradication of BTV-8 from many European countries, despite reducing levels of vaccine coverage.
尽管 2008 年至 2011 年期间,在欧洲广泛使用了蓝舌病血清 8 型(BTV-8)灭活疫苗,但对于疫苗接种后群体特异性抗体在牛奶和血清中的持续时间以及疫苗接种后一年以上的保护持续时间这两个非常实际的问题,仍有两个问题没有得到解答。本研究首先揭示了,在疫苗接种后至少 3 年内,群体特异性抗体在大多数牛的牛奶和血清中仍保持高水平,从而排除了在基于 ELISA 的监测计划中使用这些动物的可能性。其次,已表明中和抗体在大多数牛中至少持续 3 年,这表明在此期间牛可能受到保护。这种延长的保护期可能有助于 BTV-8 在许多欧洲国家迅速有效地被根除,尽管疫苗覆盖率有所降低。